INNOVIVA, INC. Gain (Loss) on Extinguishment of Debt
INNOVIVA, INC. (INVA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-02-26
- INNOVIVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for fiscal 2022 was -$20.66M.
- INNOVIVA, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | -$20.66M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | -$20.66M 10-Q · filed 2023-11-01 | -$20.66M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | -$20.66M 10-Q · filed 2023-08-02 | -$20.66M derived: sum of 3 quarters · filed 2024-03-05 | -$20.66M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | -$20.66M 10-Q · filed 2023-05-09 | -$20.66M derived: sum of 2 quarters · filed 2024-03-05 | -$20.66M derived: sum of 3 quarters · filed 2024-03-05 | -$20.66M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 10-K/A · filed 2024-03-05 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-07-27 | $0.00 10-Q · filed 2022-07-27 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | -$216.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | -$216.00K derived: sum of 2 quarters · filed 2022-03-17 | -$216.00K derived: sum of 3 quarters · filed 2022-03-17 | -$216.00K 10-K/A · filed 2022-03-17 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $0.00 10-Q · filed 2019-07-24 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | -$2.61M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | -$2.61M derived: sum of 3 quarters · filed 2021-02-25 | -$2.61M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.61M derived: sum of 2 quarters · filed 2021-02-25 | -$2.61M derived: sum of 3 quarters · filed 2021-02-25 | -$5.75M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$2.61M derived: sum of 2 quarters · filed 2019-10-30 | -$5.75M 10-Q · filed 2019-10-30 | -$5.75M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$3.14M 10-Q · filed 2019-07-24 | -$3.14M derived: sum of 3 quarters · filed 2020-02-19 | -$9.56M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-03-31 | -$3.14M 10-Q · filed 2019-05-01 | -$3.14M derived: sum of 2 quarters · filed 2020-02-19 | -$9.56M derived: sum of 3 quarters · filed 2020-02-19 | -$10.39M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$6.43M derived: sum of 2 quarters · filed 2020-02-19 | -$7.26M derived: sum of 3 quarters · filed 2020-02-19 | -$7.26M 10-K · filed 2020-02-19 | |
| 2017-09-30 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$7.26M derived: sum of 2 quarters · filed 2018-10-31 | -$7.26M 10-Q · filed 2018-10-31 | -$6.67M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-06-30 | -$830.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$830.00K 10-Q · filed 2018-07-26 | -$240.00K derived: sum of 3 quarters · filed 2019-02-19 | -$240.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-04 | $590.00K derived: sum of 2 quarters · filed 2019-02-19 | $590.00K derived: sum of 3 quarters · filed 2019-02-19 | ||
| 2016-12-31 | $590.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $590.00K derived: sum of 2 quarters · filed 2019-02-19 | $2.34M 10-K · filed 2019-02-19 | -$2.34M 10-K · filed 2017-02-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $1.75M 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | $1.75M 10-Q · filed 2017-08-08 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |